March Private Market UpdateFebruary shows slight uptick in Forge’s investor interest prior to bank turbulence
March Private Market Update
boundlessbio.comHealthcareFounded: 2018Funding to Date: $152.05MM
Boundless Bio enables the companies researchers to interrogate ecDNA biology and maintain a robust pipeline of novel oncology targets essential to the function of cancer cells that are enabled by ecDNA.
View Enterprise Value for Boundless Bio.
